Interim safety of RSVpreF vaccination during pregnancy Journal Article uri icon
Overview
abstract

  • This interim analysis of an ongoing retrospective cohort study uses data from 5 US health plans to assess safety of a bivalent prefusion F subunit–based respiratory syncytial virus (RSV) vaccine administered during pregnancy during the first full RSV season after US Food and Drug Administration approval (from September 22, 2023, through June 14, 2024).

    • Link to Article
    authors
    publication date
  • 2026
    • published in
  • JAMA  Journal
    • Research
    keywords
  • Adverse Effects
  • Pregnancy
  • Prevention
  • Respiratory Tract Infections
  • Retrospective Studies
  • Vaccination
    • Additional Document Info
    volume
  • 335
    • issue
  • 5